Barclays
CTEV

Barclays’s Claritev Corp CTEV Stock Holding History

Barclays’s Portfolio CTEV Stock Details CTEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.95M Buy
241,783
+229,990
+1,950% +$5.15M ﹤0.01% 1966
2025
Q4 		$504K Buy
11,793
+157
+1% +$7.99K ﹤0.01% 3840
2025
Q3 		$618K Sell
11,636
-2,213
-16% -$122K ﹤0.01% 3678
2025
Q2 		$625K Buy
+13,849
New +$398K ﹤0.01% 3633
2025
Q1 		– Sell
-100,000
Closed -$1.48M – 5643
2024
Q4 		$1.48M Sell
100,000
-180,000
-64% -$1.59M ﹤0.01% 3114
2024
Q3 		$2.14M Buy
280,000
+104,649
+60% +$1.23M ﹤0.01% 2797
2024
Q2 		$2.72M Buy
175,351
+167,081
+2,020% +$3.98M ﹤0.01% 1923
2024
Q1 		$268K Sell
8,270
-6,482
-44% -$273K ﹤0.01% 3959
2023
Q4 		$850K Buy
14,752
+11,567
+363% +$702K ﹤0.01% 3563
2023
Q3 		$214K Buy
3,185
+209
+7% +$15.4K ﹤0.01% 3266
2023
Q2 		$251K Sell
2,976
-1,823
-38% -$97.4K ﹤0.01% 3137
2023
Q1 		$203K Buy
4,799
+2,262
+89% +$102K ﹤0.01% 3781
2022
Q4 		$117K Sell
2,537
-1,286
-34% -$103K ﹤0.01% 4137
2022
Q3 		$437K Buy
3,823
+2,633
+221% +$436K ﹤0.01% 2782
2022
Q2 		$261K Sell
1,190
-160
-12% -$31.6K ﹤0.01% 3292
2022
Q1 		$253K Buy
+1,350
New +$222K ﹤0.01% 3278

Other funds holding CTEV

HFCIV
H&F Corporate Investors VIII San Francisco, California $133M AUM 24.42% 1-Year Est. Return
AM
Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return
ACM
Arini Captial Management London, United Kingdom $484M AUM
PIF
Public Investment Fund Al Aqiq District, Riyadh, Saudi Arabia $12B AUM 0.61% 1-Year Est. Return
BPCM
Beach Point Capital Management Santa Monica, California $258M AUM 20.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
CPV Partners Stamford, Connecticut $224M AUM 77.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Caspian Capital New York $103M AUM
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Barclays's CTEV Position: Q1 2026 in Review

Barclays increased its Claritev Corp (CTEV) stake by 1,950% in Q1 2026, buying an estimated $5.15M and bringing the position to 241,783 shares worth $3.95M. The position accounts for ﹤0.01% of the portfolio, ranked #1966.

Barclays first reported a position in CTEV in Q1 2022 and has held it in 16 quarters since. 94 funds tracked by Wall St. Rank hold CTEV as of Q1 2026.

  • Barclays held 241,783 shares of Claritev Corp worth $3.95M as of Q1 2026.
  • Barclays bought 229,990 Claritev Corp shares in Q1 2026, an estimated $5.15M.
  • Claritev Corp made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1966 holding.
  • Barclays first reported a position in Claritev Corp in Q1 2022 and has held it in 16 quarters since.
  • 94 funds tracked by Wall St. Rank held Claritev Corp as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.